Compare LTGO & DCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LTGO | DCH |
|---|---|---|
| Founded | N/A | 1994 |
| Country | United States | United States |
| Employees | N/A | 20000 |
| Industry | | Auto Parts:O.E.M. |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2026 | 1998 |
| Metric | LTGO | DCH |
|---|---|---|
| Price | $20.25 | $5.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $10.50 |
| AVG Volume (30 Days) | 226.7K | ★ 2.2M |
| Earning Date | N/A | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $5,836,700,000.00 |
| Revenue This Year | N/A | $82.65 |
| Revenue Next Year | N/A | $4.20 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.22 | $4.92 |
| 52 Week High | $25.93 | $8.75 |
| Indicator | LTGO | DCH |
|---|---|---|
| Relative Strength Index (RSI) | 46.32 | N/A |
| Support Level | N/A | N/A |
| Resistance Level | $25.17 | N/A |
| Average True Range (ATR) | 1.68 | 0.00 |
| MACD | -0.38 | 0.00 |
| Stochastic Oscillator | 15.87 | 0.00 |
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.
Dauch Corp is a world-wide Tier 1 Automotive Supplier, Dauch designs, engineers and manufactures Driveline and Metal Forming technologies to support electric, hybrid and internal combustion vehicles.